@prefix jvr: <http://data.loterre.fr/ark:/67375/JVR> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix mesh: <http://id.nlm.nih.gov/mesh/vocab#> .
@prefix dc: <http://purl.org/dc/terms/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .

jvr:-BT300B3G-Q
  skos:prefLabel "cerebrospinal fluid (Qualifier)"@en, "liquide cérébrospinal (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-L6C0XPHT-4
  skos:prefLabel "métabolisme (Qualificatif)"@fr, "metabolism (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-XV06LPML-W
  skos:prefLabel "urine (Qualifier)"@en, "urine (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-G7KXQWSR-5
  skos:prefLabel "biosynthèse (Qualificatif)"@fr, "biosynthesis (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-Z9TSGBXH-4
  skos:prefLabel "génétique (Qualificatif)"@fr, "genetics (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-Q3979798-W
  skos:prefLabel "analysis (Qualifier)"@en, "analyse (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-H7K65Q8S-Z
  skos:prefLabel "radiation effects (Qualifier)"@en, "effets des radiations (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-TJHVZCRZ-0
  skos:prefLabel "administration et posologie (Qualificatif)"@fr, "administration & dosage (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-G30ZJ446-J
  skos:prefLabel "toxicity (Qualifier)"@en, "toxicité (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-NFTHND7Q-8
  skos:prefLabel "intoxication (Qualificatif)"@fr, "poisoning (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-FWD2BGQ0-9
  skos:prefLabel "usage thérapeutique (Qualificatif)"@fr, "therapeutic use (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-THHNVC7V-3
  skos:prefLabel "synthèse chimique (Qualificatif)"@fr, "chemical synthesis (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-M63HSDM7-1
  skos:prefLabel "antagonists & inhibitors (Qualifier)"@en, "antagonistes et inhibiteurs (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-HDFPHN75-V
  skos:prefLabel "Aldose-ketose isomerases"@fr, "Aldose-Ketose Isomerases"@en ;
  a mesh:Descriptor, skos:Concept ;
  skos:narrower jvr:-ZCJSBK7Z-X .

jvr:-S0CS1X5R-5
  skos:prefLabel "immunology (Qualifier)"@en, "immunologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-HQRFT0C6-B
  skos:prefLabel "isolement et purification (Qualificatif)"@fr, "isolation & purification (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-T2TS0S41-N
  skos:prefLabel "ultrastructure (Qualifier)"@en, "ultrastructure (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-NB0XHT3S-N
  skos:prefLabel "adverse effects (Qualifier)"@en, "effets indésirables (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-W6SQV79N-S
  skos:prefLabel "classification (Qualifier)"@en, "classification (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-CB30NGKB-3
  skos:prefLabel "economics (Qualifier)"@en, "économie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr: a skos:ConceptScheme .
jvr:-SBNWSM1T-R
  skos:prefLabel "history (Qualifier)"@en, "histoire (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-D0F21513-5
  skos:prefLabel "chemistry (Qualifier)"@en, "composition chimique (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-R3QWLHRG-V
  skos:prefLabel "standards (Qualifier)"@en, "normes (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-NHL3D2X0-S
  skos:prefLabel "sang (Qualificatif)"@fr, "blood (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-T9HQD7ST-J
  skos:prefLabel "ressources et distribution (Qualificatif)"@fr, "supply & distribution (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-N2WP45CN-V
  skos:prefLabel "drug effects (Qualifier)"@en, "effets des médicaments et des substances chimiques (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-NKM836P1-M
  skos:prefLabel "pharmacology (Qualifier)"@en, "pharmacologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-WK5F724J-1
  skos:prefLabel "pharmacokinetics (Qualifier)"@en, "pharmacocinétique (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-ZCJSBK7Z-X
  skos:prefLabel "Glucose 6-phosphate isomerase"@fr, "Glucose-6-Phosphate Isomerase"@en ;
  skos:hiddenLabel "Facteur AMF"@fr, "Autocrine Motility Factor"@en, "Facteur autocrine de motilité"@fr, "Facteur de motilité autocrine"@fr, "Tumor-Cell Autocrine Motility Factor"@en, "Tumor Autocrine Motility Factor"@en, "AMF (Autocrine Motility Factor)"@fr, "EC 5.3.1.9"@fr, "EC 5.3.1.9"@en, "Neuroleukin"@en, "Facteur autocrine de mobilité"@fr ;
  skos:inScheme jvr: ;
  mesh:allowableQualifier jvr:-NKM836P1-M, jvr:-H7K65Q8S-Z, jvr:-L6C0XPHT-4, jvr:-SBNWSM1T-R, jvr:-G30ZJ446-J, jvr:-D0F21513-5, jvr:-T9HQD7ST-J, jvr:-NFTHND7Q-8, jvr:-XV06LPML-W, jvr:-THHNVC7V-3, jvr:-TJHVZCRZ-0, jvr:-FWD2BGQ0-9, jvr:-S0CS1X5R-5, jvr:-NHL3D2X0-S, jvr:-CB30NGKB-3, jvr:-M63HSDM7-1, jvr:-N2WP45CN-V, jvr:-BT300B3G-Q, jvr:-Q3979798-W, jvr:-W6SQV79N-S, jvr:-R3QWLHRG-V, jvr:-NB0XHT3S-N, jvr:-WZF2ZR3L-B, jvr:-HQRFT0C6-B, jvr:-T2TS0S41-N, jvr:-Z9TSGBXH-4, jvr:-G7KXQWSR-5, jvr:-WK5F724J-1 ;
  skos:altLabel "Phosphoglucose Isomerase"@en, "Phosphosaccharomutase"@fr, "D-glucose 6-phosphate ketol-isomerase"@fr, "Oxoisomérase"@fr, "Glucosephosphate Isomerase"@en, "Hexosephosphate isomérase"@fr, "D-Glucose-6-phosphate ketol-isomerase"@fr, "D-Glucose-6-phosphate ketol-isomerase"@en, "Phosphohexose Isomerase"@en, "Isomerase, Glucose 6 Phosphate"@en, "Phosphohexose isomérase"@fr, "Phosphoglucoisomérase"@fr ;
  dc:created "1999-01-01"^^xsd:date ;
  dc:established "1965-01-01"^^xsd:date ;
  owl:sameAs <http://id.nlm.nih.gov/mesh/D005956> ;
  a skos:Concept, mesh:Descriptor ;
  skos:broader jvr:-HDFPHN75-V ;
  dc:modified "2019-07-01"^^xsd:date ;
  skos:definition "An aldose-ketose isomerase that catalyzes the reversible interconversion of glucose 6-phosphate and fructose 6-phosphate. In prokaryotic and eukaryotic organisms it plays an essential role in glycolytic and gluconeogenic pathways. In mammalian systems the enzyme is found in the cytoplasm and as a secreted protein. This secreted form of glucose-6-phosphate isomerase has been referred to as autocrine motility factor or neuroleukin, and acts as a cytokine which binds to the AUTOCRINE MOTILITY FACTOR RECEPTOR. Deficiency of the enzyme in humans is an autosomal recessive trait, which results in CONGENITAL NONSPHEROCYTIC HEMOLYTIC ANEMIA. A secreted form of glucose-6-phosphate isomerase."@en ;
  mesh:registryNumber "EC 5.3.1.9" .

jvr:-WZF2ZR3L-B
  skos:prefLabel "physiology (Qualifier)"@en, "physiologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

